Ufenamate

乌芬那酯

Report date: 2023/03/21 10:40:04
NME

Base Information

Drug NameUfenamate
Drug Alias Name氟灭酸丁酯Flufenamic acid butyl esterButyl flufenamateEpiamart SFenazole +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsSkin Diseases, EczematousEczemaDermatitis, Seborrheic +[7] 
Global Approved IndicationsSkin Diseases, EczematousEczemaDermatitis, Seborrheic +[7] 
Approved Indications in ChinaSkin Diseases, EczematousSkin Diseases
Original Approved Country/TerritoryJapan
Original Approved Date1982/10/07
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe PharmaAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesMylan EPDShenyang Antibiotic Manufacturer
Inactive CompaniesN/A
Active IndicationsSkin Diseases, EczematousEczemaDermatitis, Seborrheic +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeM01AG03
Related LinksWikipediaKEGG